Related Experiment Video
Updated: Jun 14, 2025
High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
Phenotypic screening identified polydatin alleviating cartilage degeneration by modulating SIRT3-dependent
Aomeng Mao1, Yajing Fu1, Menghan Zhang2
1Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Hangzhou 310000, China.
Background:
Osteoarthritis (OA) is a prevalent degenerative disease, characterized by articular cartilage lesions, synovial inflammation, and osteophyte formation, which ultimately results in joint deformity and limited mobility. Polyphenols, a class of bioactive phytochemicals widely distributed in traditional Chinese medicine, have been extensively utilized for centuries in the management of OA.
Purpose:
Despite extensive research efforts, effective pharmacological interventions for treating OA have yet to be fully realized. This study aimed to identify anti-inflammatory polyphenols as potential therapeutic alternatives for osteoarthritis treatment.
Methods:
The high-content screening (HCS) technique was utilized to identify active compounds from a polyphenol library. An interleukin-1β (IL-1β) stimulated inflammatory model, which significantly increased the expression of chondrocyte degradation markers such as matrix metallopeptidase 13 (MMP-13), was established in vitro. Polydatin (PD) was identified as a promising substance for attenuating MMP-13 expression and promoting type II collagen (COL2) expression. Subsequently, destabilization of the medial meniscus (DMM) and monosodium iodoacetate (MIA) mouse models of OA were utilized to evaluate the efficacy of PD in vivo. After model establishment and drug administration, knee joints were harvested at 4 and 12 weeks post-treatment and subjected to radiological and histological assessments. Finally, mitochondrial function assays were conducted to further explore the underlying therapeutic mechanisms.
Results:
Within a library of 16 polyphenolic compounds, HCS-based phenotypic screening identified six active compounds that potently inhibited the expression of MMP-13. PD exhibited promising anti-inflammatory effects in a dose-dependent manner. Western blot and immunofluorescence analyses revealed that PD markedly suppressed MMP-13 synthesis and COL2 degradation in a dose-dependent manner. The RNA sequencing results revealed that the anti-inflammatory efficacy of PD may be associated with the Wnt signaling pathway. Three-dimensional micro-CT reconstructions revealed a reduction in osteophyte formation in the PD treatment groups relative to the OA model groups. Safranin O and fast green (SO&FG) staining, hematoxylin and eosin staining, and COL2 immunofluorescence staining revealed that PD treatment alleviated cartilage matrix breakdown and reduced osteoarthritis scores. Furthermore, PD upregulated the expression of sirtuin 3 (SIRT3) and superoxide dismutase 2 (SOD2), thereby increasing mitochondrial membrane potential and reducing mitochondrial superoxide (mtROS) levels, suggesting antioxidant-driven anti-inflammatory effects.
Conclusion:
This study successfully employed the HCS technique to identify polydatin from a polyphenol library as an active compound for treating OA. PD alleviates cartilage degradation and lesions by activating the SIRT3/SOD2/mtROS axis, increasing the mitochondrial membrane potential, and exerting antioxidant effects.
Insights
Polydatin (PD) effectively treats osteoarthritis (OA) by reducing cartilage degradation and inflammation. This natural compound activates antioxidant pathways, improving mitochondrial function and joint health.
Area of Science:
- Pharmacology
- Biochemistry
- Traditional Chinese Medicine
Background:
- Osteoarthritis (OA) is a degenerative joint disease causing cartilage lesions, inflammation, and mobility loss.
- Polyphenols, natural compounds found in traditional Chinese medicine, have a history of use in managing OA.
Purpose of the Study:
- To identify anti-inflammatory polyphenols for potential osteoarthritis treatment.
- To evaluate polydatin (PD) as a therapeutic agent for OA.
Main Methods:
- High-content screening (HCS) identified active compounds from a polyphenol library.
- In vitro models assessed chondrocyte degradation markers (MMP-13, COL2) and in vivo OA mouse models (DMM, MIA) evaluated PD's efficacy.
- Radiological, histological, and mitochondrial function assays were performed.
Main Results:
- Polydatin (PD) demonstrated dose-dependent anti-inflammatory effects, suppressing MMP-13 and COL2 degradation.
- RNA sequencing suggested the Wnt signaling pathway mediates PD's anti-inflammatory action.
- PD treatment reduced osteophyte formation, alleviated cartilage breakdown, and improved OA scores in vivo.
- PD activated the SIRT3/SOD2/mtROS axis, enhancing mitochondrial membrane potential and reducing oxidative stress.
Conclusions:
- Polydatin (PD) was identified as a promising compound for osteoarthritis treatment using HCS.
- PD alleviates OA by activating the SIRT3/SOD2/mtROS pathway, improving mitochondrial function and exerting antioxidant effects.
